These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21809300)

  • 21. [New findings with RAS inhibitors in diabetic nephropathy].
    Ito S
    Nihon Jinzo Gakkai Shi; 2007; 49(5):485-90. PubMed ID: 17695809
    [No Abstract]   [Full Text] [Related]  

  • 22. Is microalbuminuria a disease?
    Williams CD
    Pharmacotherapy; 2012 Sep; 32(9):781-3. PubMed ID: 22949141
    [No Abstract]   [Full Text] [Related]  

  • 23. The CARI guidelines. Inhibition of the renin-angiotensin system.
    Mount P; Kumar SK; MacGinley R; Mantha M; Roberts M; Mangos G;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S234-43. PubMed ID: 20591037
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.
    Makani H; Bangalore S; Romero J; Wever-Pinzon O; Messerli FH
    Am J Med; 2011 Feb; 124(2):128-35. PubMed ID: 21295192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
    Harman-Boehm I
    Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic nephropathy: common questions.
    Thorp ML
    Am Fam Physician; 2005 Jul; 72(1):96-9. PubMed ID: 16035688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
    Disertori M; Zeni P; Quintarelli S; Bonmassari R
    G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upstream therapies after pulmonary vein ablation: five negative studies--what's next?
    Savelieva I; Camm AJ
    Europace; 2010 Nov; 12(11):1509-13. PubMed ID: 20974763
    [No Abstract]   [Full Text] [Related]  

  • 30. [Albuminuria : prognostic marker or therapeutic goal?].
    Chatzikyrkou C; Haller H; Menne J
    Internist (Berl); 2012 Jan; 53(1):38-44. PubMed ID: 22231694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathway.
    Heerspink HJ
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):290-9. PubMed ID: 21782135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing diabetic nephropathy: recent studies.
    Lit YZ; Meyer T
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):111-6. PubMed ID: 16481875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Why does the patient lose protein? The state of the vessels is reflected in the urine].
    MMW Fortschr Med; 2008 Oct; 150(40):18. PubMed ID: 18990880
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.
    Viberti G; Chaturvedi N
    Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
    Kubota T; Takeshita A
    Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect on diabetic microalbuminuria of anti-hypertensive treatment].
    Sert C; Champigneulle A; Grimaldi A
    Presse Med; 1990 Mar; 19(10):471. PubMed ID: 1969631
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diabetic nephropathy. Are the blood pressure values set too low?].
    Zidek W
    MMW Fortschr Med; 2003 Dec; 145(49):14. PubMed ID: 14963985
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combination of ACEI and ARB therapy for heart failure].
    Nishikimi T; Matsuoka H
    Nihon Rinsho; 2007 May; 65 Suppl 5():140-4. PubMed ID: 17569311
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.